Mortality by causes in HIV-infected adults: Comparison with the general population

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Aldaz, Pablo ^a,b   Moreno Iribas, Conchi ^c,d   Egüés, Nerea ^c,d   Irisarri, Ftima ^c,d   Floristan, Yugo ^c,d   Sola Boneta, Julio ^e,f   Martínez Artola, Víctor ^e   Sagredo, Mirian ^e   Castilla, Jess ^c,d  

^a Centro de Salud de San Juan   (Spain)

^b SemFYC   (Spain)

^c INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e Universidad Pública de Navarra   (Spain)

^f Red de Investigación en Sida RIS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MORTALITY; SPAIN;

ADULT; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MORTALITY; SPAIN; YOUNG ADULT;

EID: 79955775563     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-300     Document Type: Article

References (35)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. FJ Palella K Delaney A Moorman MO Loveless J Fuhrer GA Satten DJ Aschman SD Holmberg, N Eng J Med 1998 338 853 860 10.1056/NEJM199803263381301 (Pubitemid 28135961)
2. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. A Mocroft B Ledergerber C Katlama O Kirk P Reiss A d'Arminio Monforte B Knysz M Dietrich AN Phillips JD Lundgren EuroSIDA Study Group, Lancet 2003 362 22 29 10.1016/S0140-6736(03)13802-0 12853195 (Pubitemid 36835816)
3. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. C Jäggy J von Overbeck B Ledergerber C Schwarz M Egger M Rickenbach HJ Furrer A Telenti M Battegay M Flepp P Vernazza E Bernasconi B Hirschel Swiss HIV Cohort Study, Lancet 2003 362 877 878 10.1016/S0140-6736(03) 14307-3 13678976 (Pubitemid 37130098)
4. All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population. O Keiser P Taffé M Zwahlen M Battegay E Bernasconi R Weber M Rickenbach the Swiss HIV Cohort Study, AIDS 2004 18 1835 1843 10.1097/00002030-200409030-00013 15316345 (Pubitemid 39179636)
5. Survival of persons with and without HIV infection in Denmark, 1995-2005. N Lohse AB Hansen G Pedersen G Kronborg J Gerstoft HT Sørensen M Vaeth N Obel, Ann Intern Med 2007 146 87 95 17227932 (Pubitemid 351640011)
6. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category. S Pérez-Hoyos J del Amo R Muga J del Romero P García de Olalla R Guerrero I Hernndez-Aguado GEMES (Spanish Multicenter Study Group of Seroconverters), AIDS 2003 17 353 359 10.1097/00002030-200302140-00009 12556689 (Pubitemid 36223260)
7. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. FJ Palella Jr RK Baker AC Moorman JS Chmiel KC Wood JT Brooks SD Holmberg HIV Outpatient Study Investigators, J Acquir Immune Defic Syndr 2006 43 27 34 10.1097/01.qai. 0000233310.90484.16 16878047 (Pubitemid 44306484)
8. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. JA Pineda JA García-García M Aguilar-Guisado MJ Ríos-Villegas J Ruiz-Morales A Rivero J del Valle R Luque J Rodríguez-Bão M Gonzlez-Serrano A Camacho J Macías I Grilo JM Gámez-Mateos Grupo para el Estudio de las Hepatitis Víricas de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI), Hepatology 2007 46 622 630 10.1002/hep.21757 17659577 (Pubitemid 47436106)
9. Trends in mortality and causes of death among persons with HIV infection, 1985-2004 (in Spanish). P Aldaz J Castilla C Moreno-Iribas F Irisarri Y Floristn J Sola-Boneta V Martínez-Artola C Fernndez-Juregui I Dorronsoro, Enferm Infecc Microbiol Clin 2007 25 5 10 10.1157/13096746 17261240 (Pubitemid 46232683)
10. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancer, persistent role of AIDS. C Lewden D Salmon P Morlat S Bévilacqua E Jougla F Bonnet L Héripret D Costagliola R May G Chne Mortality 2000 study group, Int J Epidemiol 2005 34 121 130 15561752 (Pubitemid 40347381)
11. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. J Neuhaus B Angus JD Kowalska A La Rosa J Sampson D Wenthworth A Mocroft INSIGHT SMART and ESPRIT study groups, AIDS 2010 24 697 706 10.1097/QAD.0b013e3283365356 20177360
12. Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. S Jensen-Fangel L Pedersen C Pedersen CS Larsen P Tauris A Møller HT Sørensen N Obel, AIDS 2004 18 89 97 10.1097/00002030-200401020-00011 15090834 (Pubitemid 38402322)
13. Changing patterns of mortality across Europe in patients infected with HIV-1. A Mocroft S Vella TL Benfield A Chiesi V Miller P Gargalianos A d'Arminio Monforte I Yust JN Bruun AN Phillips JD Lundgren, Lancet 1998 352 1725 1730 10.1016/S0140-6736(98)03201-2 9848347 (Pubitemid 28534954)
14. The effect of HIV infection on overdose mortality. C Wang D Vlahov N Galai SR Cole J Bareta R Pollini SH Mehta KE Nelson S Galea, AIDS 2005 19 935 942 10.1097/01.aids.0000171407.30866.22 15905674 (Pubitemid 40834936)
15. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. The Antiretroviral Therapy Cohort Collaboration, Int J Epidemiol 2009 38 1624 1633 19820106
16. Evaluation of the surveillance system for human immunodeficiency virus infections of Navarra, Spain, 1985-2003 (in Spanish). A Caro-Murillo C Moreno-Iribas F Irisarri P Aldaz V Napal C Varela Santos J Castilla, Rev Esp Salud Pblica 2007 81 387 389
17. Progress in the control of HIV infection and AIDS in Navarre, 1985-2003 (in Spanish). C Moreno-Iribas F Irisarri L Elizalde M Urtiaga J Sola C Fernndez Jauregui V Martínez De Artola J Sinz de Murieta I Dorronsoro T Rubio J Castilla, An Sist Sanit Navar 2004 27 221 231 15381954 (Pubitemid 39222366)
18. Recent trends of the main causes of death in Navarre, 1995-2004 (in Spanish). C Moreno-Iribas Y Floristn N Egüés, An Sist Sanit Navar 2006 29 399 414 17224937 (Pubitemid 46120762)
19. The National Death Index: a largely expected advance in the access to mortality data (in Spanish). C Navarro, Gac Sanit 2006 20 421 423 10.1157/13096513 17198617
20. International statistical classification of diseases and related health problems: ICD-10. World Health Organization, Geneva, Switzerland: World Health Organization 1992
21. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. JA Sterne MA Hernan B Ledergerber K Tilling R Weber P Sendi M Rickenbach JM Robins M Egger Swiss HIV Cohort Study, Lancet 2005 366 378 384 10.1016/S0140-6736(05)67022-5 16054937 (Pubitemid 41073955)
22. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of pre-, early, and late HAART (highly active antiretroviral therapy) eras. NF Crum RH Riffenburgh S Wegner BK Agan SA Tasker KM Spooner AW Armstrong S Fraser MR Wallace Triservice AIDS Clinical Consortium, J Acquir Immune Defic Syndr 2006 41 194 200 10.1097/01.qai.0000179459.31562.16 16394852
23. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. K Bhaskaran O Hamouda M Sannes F Boufassa AM Johnson PC Lambert K Porter CASCADE Collaboration, JAMA 2008 300 51 59 10.1001/jama.300.1.51 18594040 (Pubitemid 351920404)
24. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HB Krentz G Kliewer MJ Gill, HIV Med 2005 6 99 106 10.1111/j.1468-1293.2005.00271.x 15807715 (Pubitemid 40425973)
25. Delayed diagnosis of HIV infection in Spain (in Spanish). J Oliva S Galindo N Vives A Arrillaga A Izquierdo A Nicolau J Castilla ME Lezaun M Álvarez A Rivas M Diez, Enfem Infecc Microbiol Clin 2010 28 583 589 10.1016/j.eimc.2010.02.013
26. Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' surveys (ANRS EN19). M Hessamfar-Bomarek P Morlat D Salmon P Cacoub T May F Bonnet E Rosenthal D Costagliola C Lewden G Chne Mortalité 2000 & 2005 Study Groups, Int J Epidemiol 2010 39 135 146 10.1093/ije/dyp300 19805489
27. Pre-Aids mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users. M Prins I Hernndez Aguado RP Brettle JR Robertson B Broers N Carré DJ Goldberg R Zangerle RA Coutinho A van den Hoek, AIDS 1997 11 1747 1756 10.1097/00002030-199714000-00012 9386810 (Pubitemid 27470277)
28. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. F Boccara, AIDS 2008 22 Suppl 3 19 26 10.1097/01.aids.0000327512.76126.6e 18845918
29. HIV type infection, and not short-term HAART, induces endothelial dysfunction. D Francisci S Giannini F Baldelli M Leone B Belfiori G Guglielmini L Malincarne P Gresele, AIDS 2009 23 589 596 10.1097/QAD.0b013e328325a87c 19177019
30. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. P Patel DL Hanson PS Sullivan RM Novak AC Moorman TC Tong SD Holmberg JT Brooks Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators, Ann Intern Med 2008 148 728 736 18490686 (Pubitemid 351717418)
31. Trends in cancer risk among people with AIDS in the United States 1980-2002. E Engels R Pfeiffer JJ Goedert P Virgo TS McNeel SM Scoppa RJ Biggar for the HIV/AIDS Cancer Match Study, AIDS 2006 20 1645 1654 10.1097/01.aids. 0000238411.75324.59 16868446 (Pubitemid 44162407)
32. Association of cancer with AIDS-related immunosuppression in adults. M Frisch RJ Biggar EA Engels JJ Goedert AIDS-Cancer Match Registry Study Group, JAMA 2001 285 1736 1745 10.1001/jama.285.13.1736 11277828 (Pubitemid 32259908)
33. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. N Crum-Cianflone KH Hullsiek V Marconi A Weintrob A Ganesan RV Barthel S Fraser BK Agan S Wegner, AIDS 2009 23 41 50 10.1097/QAD.0b013e328317cc2d 19050385
34. Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008. O Keiser A Spoerri MW Brinkhof B Hasse A Gayet-Ageron F Tissot A Christen M Battegay P Schmid E Bernasconi M Egger Swiss HIV Cohort Study; Swiss National Cohort, Am J Psychiatry 2010 167 143 150 10.1176/appi.ajp.2009.09050651 20008942
35. An update of the impact of HIV/AIDS on life expectancy in the United States. D Lai RJ Hardy, AIDS 2004 18 1732 1734 10.1097/01.aids.0000131383.15232. 95 15280787 (Pubitemid 39095793)